SHL Telemedicine (SHLT) Competitors $1.92 -0.18 (-8.52%) As of 03/27/2025 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock SHLT vs. AIRS, TOI, CCM, HIMS, TDOC, AUNA, SBC, LFMD, GLSI, and PDEXShould you be buying SHL Telemedicine stock or one of its competitors? The main competitors of SHL Telemedicine include AirSculpt Technologies (AIRS), Oncology Institute (TOI), Concord Medical Services (CCM), Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Greenwich LifeSciences (GLSI), and Pro-Dex (PDEX). SHL Telemedicine vs. AirSculpt Technologies Oncology Institute Concord Medical Services Hims & Hers Health Teladoc Health Auna SBC Medical Group LifeMD Greenwich LifeSciences Pro-Dex AirSculpt Technologies (NASDAQ:AIRS) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, community ranking, profitability, institutional ownership, earnings and valuation. Does the media prefer AIRS or SHLT? In the previous week, AirSculpt Technologies had 1 more articles in the media than SHL Telemedicine. MarketBeat recorded 2 mentions for AirSculpt Technologies and 1 mentions for SHL Telemedicine. SHL Telemedicine's average media sentiment score of 1.89 beat AirSculpt Technologies' score of -0.22 indicating that SHL Telemedicine is being referred to more favorably in the news media. Company Overall Sentiment AirSculpt Technologies Neutral SHL Telemedicine Very Positive Do analysts prefer AIRS or SHLT? AirSculpt Technologies currently has a consensus price target of $5.00, suggesting a potential upside of 100.80%. Given AirSculpt Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe AirSculpt Technologies is more favorable than SHL Telemedicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AirSculpt Technologies 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00SHL Telemedicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in AIRS or SHLT? 91.5% of AirSculpt Technologies shares are held by institutional investors. Comparatively, 20.1% of SHL Telemedicine shares are held by institutional investors. 78.8% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor AIRS or SHLT? AirSculpt Technologies received 10 more outperform votes than SHL Telemedicine when rated by MarketBeat users. However, 100.00% of users gave SHL Telemedicine an outperform vote while only 36.67% of users gave AirSculpt Technologies an outperform vote. CompanyUnderperformOutperformAirSculpt TechnologiesOutperform Votes1136.67% Underperform Votes1963.33% SHL TelemedicineOutperform Votes1100.00% Underperform VotesNo Votes Which has preferable valuation & earnings, AIRS or SHLT? AirSculpt Technologies has higher revenue and earnings than SHL Telemedicine. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAirSculpt Technologies$180.35M0.81-$4.48M-$0.15-16.60SHL Telemedicine$55.94M0.56-$7.06MN/AN/A Which has more risk and volatility, AIRS or SHLT? AirSculpt Technologies has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of -0.17, indicating that its stock price is 117% less volatile than the S&P 500. Is AIRS or SHLT more profitable? SHL Telemedicine has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -4.13%. AirSculpt Technologies' return on equity of 2.22% beat SHL Telemedicine's return on equity.Company Net Margins Return on Equity Return on Assets AirSculpt Technologies-4.13% 2.22% 0.90% SHL Telemedicine N/A N/A N/A SummaryAirSculpt Technologies beats SHL Telemedicine on 12 of the 15 factors compared between the two stocks. Remove Ads Get SHL Telemedicine News Delivered to You Automatically Sign up to receive the latest news and ratings for SHLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHLT vs. The Competition Export to ExcelMetricSHL TelemedicineOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.43M$1.12B$5.64B$8.06BDividend YieldN/AN/A4.56%4.02%P/E RatioN/A18.3723.1319.03Price / Sales0.561.12383.8993.17Price / Cash54.0336.0138.1634.64Price / Book0.378.776.944.33Net Income-$7.06M-$52.07M$3.20B$247.06M7 Day Performance-19.39%-0.37%-2.30%-0.52%1 Month Performance-18.22%-12.39%3.10%-3.73%1 Year Performance-69.02%-26.69%11.22%1.74% SHL Telemedicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHLTSHL TelemedicineN/A$1.92-8.5%N/A-69.0%$34.43M$55.94M0.00583Positive NewsGap DownAIRSAirSculpt Technologies1.4164 of 5 stars$2.63-8.0%$5.00+90.1%-60.4%$152.23M$188.78M-18.79240Short Interest ↑High Trading VolumeTOIOncology Institute0.2 of 5 stars$0.70+7.4%N/A-39.7%$52.97M$378.93M-0.90660Earnings ReportCCMConcord Medical Services0.5508 of 5 stars$4.53+2.1%N/A-27.0%$19.28M$471.70M0.00970Short Interest ↑HIMSHims & Hers Health3.2618 of 5 stars$34.68+4.6%$37.23+7.4%+103.1%$7.70B$1.48B78.821,046Insider TradeTDOCTeladoc Health3.1919 of 5 stars$8.86+2.8%$11.26+27.1%-44.0%$1.54B$2.57B-1.545,100AUNAAuna3.8652 of 5 stars$7.08+2.8%$13.53+91.0%-31.4%$523.41M$4.39B18.6314,958SBCSBC Medical GroupN/A$3.30+1.2%N/AN/A$339.97M$223.34M0.00N/AAnalyst RevisionNews CoverageGap UpLFMDLifeMD1.8684 of 5 stars$5.71-3.9%$11.43+100.2%-45.0%$254.58M$212.45M-8.92230Short Interest ↑GLSIGreenwich LifeSciences2.2496 of 5 stars$12.21+1.8%$38.00+211.2%-46.5%$160.50MN/A-15.263News CoveragePDEXPro-Dex1.3744 of 5 stars$48.89-1.6%$52.00+6.4%+187.1%$159.43M$61.00M24.32140Insider TradeShort Interest ↑News Coverage Remove Ads Related Companies and Tools Related Companies AIRS Competitors TOI Competitors CCM Competitors HIMS Competitors TDOC Competitors AUNA Competitors SBC Competitors LFMD Competitors GLSI Competitors PDEX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHLT) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SHL Telemedicine Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SHL Telemedicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
